申请人:Ehara Takeru
公开号:US20090192148A1
公开(公告)日:2009-07-30
The invention relates to 3,5-substituted piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-substituted piperidine compound, and/or a method of treatment comprising administering a 3,5-substituted piperidine compound, a method for the manufacture of a 3,5-substituted piperidine compound, and novel intermediates and partial steps for its synthesis.
The compounds have the formula I′
wherein R1, R2, T, R3 and R4 areas defined in the specification.
本发明涉及3,5-取代哌啶化合物,这些化合物用于诊断和治疗温血动物,特别是用于治疗依赖肾素活性的疾病(=失调);该类化合物用于制备治疗依赖肾素活性疾病的制剂;该类化合物用于治疗依赖肾素活性的疾病;包括3,5-取代哌啶化合物的制药配方和/或包括给予3,5-取代哌啶化合物的治疗方法,以及制造3,5-取代哌啶化合物的新型中间体和部分合成步骤。该化合物的式子为I',其中R1、R2、T、R3和R4在规范中有定义。